Literature DB >> 2544997

Human diabetes associated with a deletion of the tyrosine kinase domain of the insulin receptor.

M Taira1, M Taira1, N Hashimoto, F Shimada, Y Suzuki, A Kanatsuka, F Nakamura, Y Ebina, M Tatibana, H Makino.   

Abstract

The insulin receptor has an intrinsic tyrosine kinase activity that is essential for signal transduction. A mutant insulin receptor gene lacking almost the entire kinase domain has been identified in an individual with type A insulin resistance and acanthosis nigricans. Insulin binding to the erythrocytes or cultured fibroblasts from this individual was normal. However receptor autophosphorylation and tyrosine kinase activity toward an exogenous substrate were reduced in partially purified insulin receptors from the proband's lymphocytes that had been transformed by Epstein-Barr virus. The insulin resistance associated with this mutated gene was inherited by the proband from her mother as an apparently autosomal dominant trait. Thus a deletion in one allele of the insulin receptor gene may be at least partly responsible for some instances of insulin-resistant diabetes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544997     DOI: 10.1126/science.2544997

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  27 in total

Review 1.  Diabetes mellitus.

Authors:  A B Johnson; R Taylor
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

2.  Defects in insulin binding and receptor kinase in cells from a woman with type A insulin resistance and from her family.

Authors:  Y Suzuki; N Hashimoto; F Shimada; M Taira; M Mimura; O Nozaki; M Tawata; T Onaya; H Makino; S Yoshida
Journal:  Diabetologia       Date:  1991-02       Impact factor: 10.122

3.  In vivo stimulation of the insulin receptor kinase in human skeletal muscle. Correlation with insulin-stimulated glucose disposal during euglycemic clamp studies.

Authors:  G R Freidenberg; S L Suter; R R Henry; D Reichart; J M Olefsky
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

4.  Abnormal messenger ribonucleic acid (mRNA) transcribed from a mutant insulin receptor gene in a patient with type A insulin resistance.

Authors:  F Shimada; Y Suzuki; M Taira; N Hashimoto; O Nozaki; H Makino; S Yoshida
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

5.  Transdominant inhibition of tyrosine kinase activity in mutant insulin/insulin-like growth factor I hybrid receptors.

Authors:  J L Treadway; B D Morrison; M A Soos; K Siddle; J Olefsky; A Ullrich; D A McClain; J E Pessin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

Review 6.  Insulin resistance due to mutations of the insulin receptor gene: an overview.

Authors:  D Accili; A Cama; F Barbetti; H Kadowaki; T Kadowaki; S I Taylor
Journal:  J Endocrinol Invest       Date:  1992-12       Impact factor: 4.256

7.  Severe insulin resistance alters metabolism in mesenchymal progenitor cells.

Authors:  Bharti Balhara; Alison Burkart; Vehap Topcu; Youn-Kyoung Lee; Chad Cowan; C Ronald Kahn; Mary-Elizabeth Patti
Journal:  Endocrinology       Date:  2015-03-26       Impact factor: 4.736

8.  The association of phosphoinositide 3-kinase enhancer A with hepatic insulin receptor enhances its kinase activity.

Authors:  Chi Bun Chan; Xia Liu; Kunyan He; Qi Qi; Dae Y Jung; Jason K Kim; Keqiang Ye
Journal:  EMBO Rep       Date:  2011-07-01       Impact factor: 8.807

9.  Sequential cleavage of insulin receptor by calpain 2 and γ-secretase impairs insulin signalling.

Authors:  Tomoyuki Yuasa; Kikuko Amo-Shiinoki; Shuhei Ishikura; Mitsuyoshi Takahara; Takaaki Matsuoka; Hideaki Kaneto; Akio Kuroda; Munehide Matsuhisa; Seiichi Hashida
Journal:  Diabetologia       Date:  2016-09-30       Impact factor: 10.122

10.  Transposon tagging of tobacco mosaic virus resistance gene N: its possible role in the TMV-N-mediated signal transduction pathway.

Authors:  S P Dinesh-Kumar; S Whitham; D Choi; R Hehl; C Corr; B Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.